132 related articles for article (PubMed ID: 7515310)
1. Monoaminergic neuronal activity in subcortical brain regions in essential hypertension.
Lambert GW; Ferrier C; Kaye DM; Kalff V; Kelly MJ; Cox HS; Turner AG; Jennings GL; Esler MD
Blood Press; 1994 Mar; 3(1-2):55-66. PubMed ID: 7515310
[TBL] [Abstract][Full Text] [Related]
2. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension.
Ferrier C; Jennings GL; Eisenhofer G; Lambert G; Cox HS; Kalff V; Kelly M; Esler MD
J Hypertens; 1993 Nov; 11(11):1217-27. PubMed ID: 8301103
[TBL] [Abstract][Full Text] [Related]
3. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity.
Lambert GW; Eisenhofer G; Cox HS; Horne M; Kalff V; Kelly M; Jennings GL; Esler MD
Life Sci; 1991; 49(15):1061-72. PubMed ID: 1895870
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension.
Esler M; Lambert G; Vaz M; Thompson J; Kaye D; Kalff V; Kelly M; Turner A; Jennings G
Clin Exp Hypertens; 1997; 19(5-6):577-90. PubMed ID: 9247740
[TBL] [Abstract][Full Text] [Related]
5. Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans.
Mitchell DA; Lambert G; Secher NH; Raven PB; van Lieshout J; Esler MD
J Physiol; 2009 Jun; 587(Pt 11):2589-97. PubMed ID: 19403604
[TBL] [Abstract][Full Text] [Related]
6. Cerebral noradrenaline spillover and its relation to muscle sympathetic nervous activity in healthy human subjects.
Lambert GW; Thompson JM; Turner AG; Cox HS; Wilkinson D; Vaz M; Kalff V; Kelly MJ; Jennings GL; Esler MD
J Auton Nerv Syst; 1997 May; 64(1):57-64. PubMed ID: 9188086
[TBL] [Abstract][Full Text] [Related]
7. Cerebral metabolism and its relationship with sympathetic nervous activity in essential hypertension: evaluation of the Dickinson hypothesis.
Lambert GW; Vaz M; Rajkumar C; Cox HS; Turner AG; Jennings GL; Esler MD
J Hypertens; 1996 Aug; 14(8):951-9. PubMed ID: 8884549
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system noradrenergic and dopaminergic turnover in response to acute neuroleptic challenge.
Lambert GW; Horne M; Kalff V; Kelly MJ; Turner AG; Cox HS; Jennings GL; Esler MD
Life Sci; 1995; 56(19):1545-55. PubMed ID: 7723582
[TBL] [Abstract][Full Text] [Related]
9. Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body sympathetic activity in human heart failure.
Aggarwal A; Esler MD; Lambert GW; Hastings J; Johnston L; Kaye DM
Circulation; 2002 Mar; 105(9):1031-3. PubMed ID: 11877349
[TBL] [Abstract][Full Text] [Related]
10. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.
Lambert GW; Kaye DM; Lefkovits J; Jennings GL; Turner AG; Cox HS; Esler MD
Circulation; 1995 Oct; 92(7):1813-8. PubMed ID: 7545554
[TBL] [Abstract][Full Text] [Related]
11. Pineal melatonin and brain transmitter monoamines in CBA mice during chronic oral nicotine administration.
Gäddnäs H; Pietilä K; Alila-Johansson A; Ahtee L
Brain Res; 2002 Dec; 957(1):76-83. PubMed ID: 12443982
[TBL] [Abstract][Full Text] [Related]
12. The effects of ethanol in combination with the alpha 2-adrenoceptor agonist dexmedetomidine and the alpha 2-adrenoceptor antagonist atipamezole on brain monoamine metabolites and motor performance of mice.
Idänpään-Heikkilä JJ; Björn M; Seppälä T
Eur J Pharmacol; 1995 Jan; 292(2):191-9. PubMed ID: 7536679
[TBL] [Abstract][Full Text] [Related]
13. Release of noradrenaline into the cerebrovascular circulation in patients with primary hypertension.
Esler MD; Jennings GL; Lambert GW
J Hypertens Suppl; 1988 Dec; 6(4):S494-6. PubMed ID: 3241241
[TBL] [Abstract][Full Text] [Related]
14. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
Esler M; Lambert E; Alvarenga M; Socratous F; Richards J; Barton D; Pier C; Brenchley C; Dawood T; Hastings J; Guo L; Haikerwal D; Kaye D; Jennings G; Kalff V; Kelly M; Wiesner G; Lambert G
Stress; 2007 Aug; 10(3):295-304. PubMed ID: 17613943
[TBL] [Abstract][Full Text] [Related]
15. Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity.
Lambert GW; Kaye DM; Thompson JM; Turner AG; Cox HS; Vaz M; Jennings GL; Wallin BG; Esler MD
Acta Physiol Scand; 1998 Jun; 163(2):155-63. PubMed ID: 9648634
[TBL] [Abstract][Full Text] [Related]
16. Effects of DM-9384, a pyrrolidone derivative, on ischemia-induced changes in the central monoamine systems.
Luthman J; Lindqvist E; Dell'Anna E; Kojima H; Shiotani T; Tachizawa H; Olson L
Pharmacol Biochem Behav; 1992 Jan; 41(1):231-4. PubMed ID: 1371610
[TBL] [Abstract][Full Text] [Related]
17. Correlative analysis of dopaminergic and serotonergic metabolism across the brain to study monoaminergic function and interaction.
Dellu-Hagedorn F; Fitoussi A; De Deurwaerdère P
J Neurosci Methods; 2017 Mar; 280():54-63. PubMed ID: 28161298
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans.
Esler MD; Lambert GW; Ferrier C; Kaye DM; Wallin BG; Kalff V; Kelly MJ; Jennings GL
Clin Exp Hypertens; 1995; 17(1-2):409-23. PubMed ID: 7735286
[TBL] [Abstract][Full Text] [Related]
19. Relationship between 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in saliva and plasma of healthy volunteers.
Yang RK; Yehuda R; Holland DD; Knott PJ
Biol Psychiatry; 1997 Nov; 42(9):821-6. PubMed ID: 9347131
[TBL] [Abstract][Full Text] [Related]
20. Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease.
Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; De Deyn PP
J Alzheimers Dis; 2014; 41(3):819-33. PubMed ID: 24685637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
